These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 7287679

  • 1. Comparative studies on the structures of highly active and relatively inactive forms of whale heparin.
    Ototani N, Kikuchi M, Yosizawa Z.
    J Biochem; 1981 Jul; 90(1):241-6. PubMed ID: 7287679
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K, Uchiyama H.
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [Abstract] [Full Text] [Related]

  • 3. Thrombin-inhibitory activity of whale heparin oligosaccharides.
    Ototani N, Kodama C, Kikuchi M, Yosizawa Z.
    J Biochem; 1984 Dec; 96(6):1695-703. PubMed ID: 6530392
    [Abstract] [Full Text] [Related]

  • 4. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
    Ototani N, Kikuchi M, Yosizawa Z.
    Biochem J; 1982 Jul 01; 205(1):23-30. PubMed ID: 7126178
    [Abstract] [Full Text] [Related]

  • 5. Separation of heparin into fractions with different anticoagulant activity by hydrophobic interaction chromatography.
    Ogamo A, Uchiyama H, Nagasawa K.
    Biochim Biophys Acta; 1980 Dec 16; 626(2):477-85. PubMed ID: 7213665
    [Abstract] [Full Text] [Related]

  • 6. The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group.
    Lindahl U, Bäckström G, Thunberg L.
    J Biol Chem; 1983 Aug 25; 258(16):9826-30. PubMed ID: 6885772
    [Abstract] [Full Text] [Related]

  • 7. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
    Shimotori T, Sakuragawa N.
    Semin Thromb Hemost; 1990 Oct 25; 16 Suppl():71-6. PubMed ID: 1962909
    [Abstract] [Full Text] [Related]

  • 8. Structure of the antithrombin-binding site in heparin.
    Lindahl U, Bäckström G, Höök M, Thunberg L, Fransson LA, Linker A.
    Proc Natl Acad Sci U S A; 1979 Jul 25; 76(7):3198-202. PubMed ID: 226960
    [Abstract] [Full Text] [Related]

  • 9. Anticoagulant activity of heparin octasaccharide.
    Ototani N, Yosizawa Z.
    J Biochem; 1981 Nov 25; 90(5):1553-6. PubMed ID: 7338523
    [Abstract] [Full Text] [Related]

  • 10. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
    Andrade-Gordon P, Strickland S.
    Proc Natl Acad Sci U S A; 1990 Mar 25; 87(5):1865-9. PubMed ID: 2106684
    [Abstract] [Full Text] [Related]

  • 11. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.
    Beecher CN, Manighalam MS, Nwachuku AF, Larive CK.
    Anal Bioanal Chem; 2016 Feb 25; 408(6):1545-55. PubMed ID: 26758598
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P, Osima B, Parma B, Nader HB, Dietrich CP.
    J Pharmacol Exp Ther; 1982 Feb 25; 220(2):406-10. PubMed ID: 7057400
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
    Bhargava AS, Freihube G, Günzel P.
    Arzneimittelforschung; 1980 Feb 25; 30(10):1621-3. PubMed ID: 7192096
    [Abstract] [Full Text] [Related]

  • 14. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK, Nader HB, Dietrich CP.
    Arzneimittelforschung; 1985 Feb 25; 35(11):1620-3. PubMed ID: 4091864
    [Abstract] [Full Text] [Related]

  • 15. Contribution of chemical 6-O-sulfation of the aminodeoxyhexose residues in whale heparin with high affinity for antithrombin III to its anticoagulant properties.
    Uchiyama H, Metori A, Ogamo A, Nagasawa K.
    J Biochem; 1990 Mar 25; 107(3):377-80. PubMed ID: 2341372
    [Abstract] [Full Text] [Related]

  • 16. An improved method for removal of antithrombin III from post-heparin plasma lipase fractions with a high recovery rate.
    Moriguchi EH, Tamachi H, Homma Y, Goto Y.
    Tokai J Exp Clin Med; 1991 Mar 25; 16(1):33-41. PubMed ID: 1780907
    [Abstract] [Full Text] [Related]

  • 17. Isolation and characterization of heparin from human mastocytoma tissue.
    Thunberg L, Höök M, Lindahl U, Abildgaard U, Langholm R.
    Thromb Haemost; 1980 Dec 19; 44(3):125-9. PubMed ID: 6781095
    [Abstract] [Full Text] [Related]

  • 18. Binding of heparin fractions and other polysulfated polysaccharides to plasma fibronectin: effects of molecular size and degree of sulfation of polysaccharides.
    Ogamo A, Nagai A, Nagasawa K.
    Biochim Biophys Acta; 1985 Jul 26; 841(1):30-41. PubMed ID: 2861857
    [Abstract] [Full Text] [Related]

  • 19. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H, Fujimoto N, Sakurai K, Nagasawa K.
    J Chromatogr; 1984 Mar 30; 287(1):55-66. PubMed ID: 6725457
    [Abstract] [Full Text] [Related]

  • 20. Preparation of biologically active fluorescent heparin composed of fluorescein-labeled species and its behavior to antithrombin III.
    Uchiyama H, Nagasawa K.
    J Biochem; 1981 Jan 30; 89(1):185-92. PubMed ID: 6783633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.